CARLSBAD, Calif., Dec. 7 /PRNewswire-FirstCall/ -- Ardea Biosciences,
Inc. (Nasdaq: RDEA) today announced that its President and Chief Executive
Officer, Barry D. Quart, PharmD, will participate in the "In Search of the
Next HIV Treatment" panel discussion at the RBC Capital Markets 2007
Healthcare Conference on Wednesday, December 12, 2007 at 1:30 p.m. (ET) at
the Westin Times Square Hotel in New York City. A live audio webcast of the
presentation and panel discussion will be accessible through Ardea's
Investor Center web site at http://www.ardeabio.com.
Event: RBC Capital Markets Healthcare Conference
Presenter: Barry D. Quart, PharmD, President and Chief Executive Officer,
Date: Wednesday, December 12, 2007
Time: 1:30 p.m. Eastern Time
Location: The Westin Times Square, New York City
About Ardea Biosciences, Inc.
Ardea Biosciences is focused on the discovery and development of small-molecule therapeutics for the treatment of viral diseases, cancer and inflammatory diseases. The Company plans to have active development programs with four new chemical entities (NCEs) in the clinic for three distinct indications by the end of 2007, with an additional one-to-two indications in inflammatory diseases planned for the first half of 2008.
Ardea's most advanced clinical development programs include: RDEA806,
the Company's lead non-nucleoside reverse transcriptase inhibitor (NNRTI)
for the treatment of HIV, which is expected to enter a Phase 2a clinical
trial in the fourth quarter of 2007; RDEA119,
|SOURCE Ardea Biosciences, Inc.|
Copyright©2007 PR Newswire.
All rights reserved